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A multicentre evaluation of the Monarch centrifugal analyser is
reported. Precision, linearity and accuracy were assessed by
comparison with routine methods. Calibration stability, photo-
metric and dispensing accuracy, and carry-over related to samples
and reagents were also evaluated. The overall performance of the
instrument was good, showing an excellent photometric and
dispensing accuracy, absence ofsample-dependent carry-over, and
almost negligible reagent carry-over. Goodprecision, linearity and
correlation with routine methods were found for the parameters
tested. The instrument is reliable and is now used as the routine
clinical chemistry analyser in two of the three laboratories taking
part in the evaluation.
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Introduction
The Monarch is an automatic random access centrifugal
analyser for clinical chemistry determinations. Random
analysis of samples is possible using a robotic system to
Table 1. Methods used on the Monarch and on the comparison instrument.
Monarch
Volumes (zl)
Parameters Wavelength Sam- Re-
tested Principles (nm) ple agent(s) Company
Comparison methods
Principles Company Analyser
Glucose hexokinase/G6PDH 340/380 3 200 IL
(EP)
Cholesterol chol. oxid./trinder 500/690 2 200 IL
(EP)
Total bilirubin sulphanilic ac. SDS 550/620 8 50/72 IL (Italy)
(EP)
Urate uricase/trinder (EP) 550/690 4 100 IL (Italy)
Total protein biuret (EP) 550/620 5 200 IL
Calcium cresolphtalein com- 570/650 4 180 IL
plexone (EP)
Phosphate unreduced phosmo- 340/520 4 150 IL (Italy)
libdate (EP)
Triglyceride lipase/glycerol 340 3 150 IL
kinase/UV (FX)
Creatinine picric acid (FX) 520 9 150 IL
Urea urease/GLDH (FX) 340 2 200 IL
AST Scandinavian Soc. 340 16 100/37 IL (Italy)
37C (K)
ALT Scandinavian Soc. 340 16 100/37 IL (Italy)
37C (K)
ALP Scandinavian Soc. 405 2 150/50 IL (Italy)
37C (K)
Sodium I.S.E. 30 1080 IL
Potassium I.S.E. 30 1080 IL
Chloride I.S.E. 30 1080 IL
Magnesium calmagite (EP) 650/570 2 200 Lancer
Iron ferene-S (EP) 600/690 25 60/60 Sentinel
hexokinase/ BM" Hitachi
G6PDH 737
chol. oxid./trinder Miles Hitachi
737
Jendrassik BM Hitachi
737
lipase/glycerol Miles Hitachi
trinder 737
picric acid kinetic BM Hitachi
737
urease/GLDH BM Hitachi
737
IFCC 37C with- BM Hitachi
out P5P 737
IFCC 37C with- BM Hitachi
out P5P 737
diethanolamine BM Hitachi
buffer 37C 737
flame photometry IL IL 943
flame photometry IL IL 943
coulometry Eppendorf 6610
atomic absorption Pie SP9000
Unicam
ferrozine Merck ERIS
Notes: EP end-point; FX fixed time; and K kinetic. ]" Boehringer Mannheim.
206
0142-0453/89 $3.00 ( 1989 Taylor & Francis Ltd.F. Ceriotti et al. Evaluation of the Monarch clinical chemistry analyser
change the disposable cuvette rotors automatically. The
disposable reaction rotors, made of UV-transmitting
plastic material, contain 39 usable optical cuvettes, all
with a pathlength of 0"744 + 0"013 cm (and a reference
cuvette). The instrument can deliver sample volumes
between 2 and 89 1 with a minimum reaction volume of
150 tl and a maximum of 260 tl. It is able to perform
colorimetric, nephelometric and fluorimetric analyses,
and, in a separate module of the instrument, potentio-
metric tests. The optical unit consists of a monochroma-
tor (wavelength between 300 and 800 nm), and 12
interference filters (from 340 to 690 nm) with a band-
width of about +1"5 nm. An optional ISE module
determines sodium, potassium and chloride using the
indirect potentiometric technique.
The Monarch has a refrigerated reagent tray (15 C) that
can hold up to 20 wedge-shaped reagent boats (maximum
capacity 16 ml); the sample ring holds up to 44 cups, 38
sample or control positions and six calibrator positions.
The instrument is programmed via a keyboard and a
video display unit with a user-friendly menu.
The theoretical throughput ofthe instrument is about 400
results/h when performing photometric analyses, and
about 600 results/h when the ISE module is included.
The Monarch automatically organizes the analytical
cycle to maximize throughput, which depends upon the
number of samples, the number of analyses per sample
and whether one or two reagents are being used.
The evaluation reported here took photometric analyses
(biochromatic equilibrium, fixed time, kinetic) and the
ISE module into account. Additionally, general features,
such as photometric performance and dispensing and
diluting accuracy using a bichromate solution, were
considered.
The work was done on three different instruments
installed in three laboratories. For practical and organi-
zational reasons it was not possible to perform every
experiment in each laboratory, as defined in the ECCLS
multicentre evaluation protocol ]; therefore each parti-
cipating laboratory performed a different part of the
evaluation, but some critical tests were repeated in more
than one laboratory.
Materials and methods
Reagents
Table shows the reagent and methods used both on
Monarch and the comparison instrument.
The Monarch was calibrated with four different
calibrators:
(1) ReferrIL A (lot No. 6071) for glucose, urea, creati-
nine, phosphate, sodium, potassium and chloride
(lab 1).
(2) ReferrIL B (lot No. 6051) for cholesterol, total
protein, sodium, potassium and chloride (lab 1).
(3) ReferrIL 3 C (lot No. 6071) for bilirubin (lab 1) and
urate.
(4) Ultimate (Beckman lot No. M 791935) for bilirubin
(lab 2).
The within- and between-batch imprecision was evalu-
ated using the following materials:
(1) Pool of normal sera, subdivided in aliquots and
stored at -20 C.
(2) Precinorm U lot No. 153148 (Boehringer
Mannheim).
(3) PrecipathU lot No. 152794 (Boehringer Mannheim).
(4) Serachem Lipid lot No. 221085 (Fisher Scientific
Orangeburg, New York 10962, USA) (only for
cholesterol and triglycerides high level).
Table 2. Imprecision of the Monarch.
Level I
CVw CVb CVo
Mean (%) (%) (%) Mean
Level H Level III
CVw CVb CVo CVw CVb CVo
(%) (%) (%) Mean (%) (%) (%)
Glucose (mmol/1) 5"026 1"73 1"47 2"27 6"602
Cholesterol (rnmol/1) 2"886 3"21 4"09 5"20 5’191
Total bilirubin (Bmol/1) 10"76 1’85 2"28 2"93 38"39
Triglyceride (mmol/1) 0"982 1"95 2"50 3"17 1"149
Urea (mrnol/1) 6"173 2"01 3"99 4"47 10’106
Creatinine (trnol/1) 86.45 2"84 4"29 5’20 183"87
AST (U/l) 17"50 2"86 2"13 3"57 59"00
ALT (U/l) 11"87 4"35 4"89 6"55 48"00
ALP (U/l) 174.91 1"28 1"18 1’74 333"93
Na (mmol/1) 119.43 0"47 0"74 0"87 136"69
K (mmol/1) 4.308 0’61 1"01 1"18 4.437
C1 (mmol/1) 101"08 0"50 0’88 1"01 106"52
1"60 1"29 2"06 14"848 0"94 1"02 1"38
2"21 2"96 3"70 8"023 1"53 2"20 2"68
1"18 2’03 2"35 98"15 0"59 2"41 2’48
2"42 2"36 3"38 3"392 1"37 1"95 2"38
2’39 2’44 3"42 22"67 1"40 2" 19 2"60
2"03 2"61 3"30 296"67 1"48 1"83 2"35
1"35 2"08 2"48 130"40 0"96 1"66 1"92
1"35 0"39 1"41 112"42 0"75 0"95 1"21
2"80 2"53 3"77 529"40 1"74 1"34 2"20
0’52 0’70 0"88 143"14 0"51 0’69 0"86
0"47 0"82 0"94 6"320 0"54 1" 12 1"25
0"44 0’90 1.01 121"40 0"51 1"08 1" 19
Notes: w, within batch; b, between batch; o, overall.
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Table 3. Calibration stability.
Period
No. days No. results Slope
Trend
probability p"
Glucose 68 37 -0"425
Urea 69 38 3"093
Creatinine 57 30 0"251
Cholesterol 67 41 -0"928
Urate 71 38 0"107
Total bilirubin 54 36 0" 173
Total protein 71 41 0" 120
Calcium 69 36 4"221
Phosphate 64 40 2"268
Magnesium 36 32 -0"397
Iron 30 25 0"052
-0"0699
0’4308
0"3265
-0"1303
0"0852
0"1688
0’1020
0"3913
0"2994
-0"4435
0’3178
0"677
0"007;
0"078
0’417
0"610
0"320
0"526
0.018
0.060
0.011
0’121
"
Probability that the slope significantly differs from 0, calculated by Student’s t-test.
++ Significant trend probability.
Table 4. Photometric accuracy; bichromate solution analysed with the pre-load mode.
Theoretical Instrument
Dilution values Abs" Abs (CV%) A%
Instrument 2
Abs (CV%) A%
0"667 0’690 (0"4) +3"45
2 0"995 1"010 (0’6) + 1"51
3 1"320 1.310 (0"5) -0"76
4 1"6413 1"650 (0"5) +0"53 ’620 (0"3) -1’3
Obtained on Uvikon 860 spectrophotometer.
Quality control materials were reconstituted at the
beginning of each working day.
Bichromate stock solution: 20 mmol/1 of potassium bichro-
mate in H2SO4 0"01 N.
Experimental design
Imprecision" materials at three different levels of concen-
tration were analysed five times per day for 10 days.
Calibration stability: the absorbances of the calibrators
were recorded during a period of 30 to 71 days, and a
regression analysis was performed to evaluate the pos-
sible presence of any significant trends.
Photometric and dispensing accuracy: the rotor was loaded
manually, independently of the instrument, with several
dilutions of the bichromate stock solution and then
analysed with the ’pre-load’ mode (this option enables
the instrument to be used just as a photometer) using a
wavelength of340/690 nm. The theoretical absorbance of
the bichromate solutions were obtained on an Uvikon 860
spectrophotometer (Kontron Instruments). The same
solution as above, and a dilution of 1:5 of it, were assayed
as samples using increasing sample volumes (from 2 to 20
tl), diluted with a constant volume of 180 tl of distilled
water; a whole rotor was run for each tested volume. Ten
to 100 tl ofa 1:37 dilution ofthe same solution were then
dispensed with the reagent pipette (setting the sample
volume to zero) and diluted with a constant volume of 100
tl of distilled water.
Table 5. Sample dispensing accuracy: bichromate solution analysed as sample.
Reference Instrument Instrument 2
Dilution values AbsJ" Abs (CV%) A% Abs (CV%) A%
2 0"690J" 0"680 (1’8) -1"47 0’710 (0"7)
3 l’010J" 1’010 (1"4) 0"00 1.010 (0"4)
4 1"310" 1"310 (1"0) 0"00 1’310 (0"6)
5 1.650l" 1.630 (0.9) 1.21 1.620 (0.6)
5; 0.3273 0.320 (2.2) -2.20 0.303 (1.5)
I0+ + O.6395 O.63O (0.8) 1.49 0.624 I.
15+ + 0.9341 0.920 (0.7) -1.51 0.927 (0.9)
20 1.2110 1.210 (0.8) -0.08 1.214 (0.9)
+2.90
0.00
0.00
1"82
-7.42
-2"42
-0.76
+0’25
Obtained on the Monarch n.1 with the ’pre-load’ mode (see text).
Bichromate solution diluted 1"5, theoretical absorbances calculated from the Uvikon values.
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Table 6. Dispensing accuracy: bichromate as reagent.
Theoretical Instrument
tl values Abs Abs (CV% A%
Instrument 2
Abs (CV%) A %
10 0.1492 0.150 (1"2) +0.54
20 0"2735 0"260 (0"8) -4.92
30 0.3793 0.360 (0.4) -5"09
50 0.5471 0.525 (0.5) -4.04
80 0"7290 0"710 (0"3) -2"61
100 0"8200 0"790 (0.4) -3"66
0"143 (4"2) -4.16
0"265 (4"2) -3.11
0"362 (1.3) -4.56
0"512 (0"5) -6"42
0"686 (0"6) -5.90
0"770 (0"6) -6"10
Table 7. Method linearity.
Analyte Range tested
Claimed
limits
Curvilinearity
r probability]"
Glucose
Triglyceride
Total bilirubin
Urea
Creatinine
AST
ALT
ALP
Sodium
Potassium
Chloride
4"4-38"8 mmol/1
0"9-12"2 mmol/1
5’ 1-431 mol/1
4"8-30"8 mmol/1
97"2-1485 mol/1
23-191 U/1
27-393 U/1
123-1350 U/1
99-158 mmol/1
"6-15"2 mmol/1
80-173 mmol/1
27"7 0"99953 0"1221
11"3 0"99897 0"0346
340 0"99995 0"1346
33"3 0"99963 0"0868
1326 0"99204 0"3504
300 0"99979 0"0825
300 0"99990 0"0500
1000 0"99916 0"1941
120-160 0"99981 0"6810
2"0-8"0 0"99900 0"8000
75-120 0"99900 0"1000
According to Burnett and Martin [3, 4].
Method linearity: samples containing high levels of analyte
were diluted, in varying proportions, with sera with low
levels of analyte. Each dilution was then measured in
duplicate.
Method comparison: 60-120 patient samples were analysed
on the Monarch, in five-10 runs, over three weeks for
each analyte. Results were compared with those obtained
by methods and instruments in routine use in the
evaluators’ laboratories (see tables and 8).
Specimen-dependent carry-over." this was assessed by running
six sequences of three high samples (H) followed by three
low ones (L). The carry-over was calculated using the
formula:
L1 (L2 + L3)/2
H3- (L2 + L3)/2
Method-to-method carry-over: this was evaluated by analys-
ing a mid-level human serum pool, in triplicate, so that
Table 8. Method comparison.
Analyte N i Slope Intercept r Sxy
Glucose mmol/1 116 6" 199
Cholesterol mmol/l 129 4"431
Total bilirubin mol/1 60 60" 14
Triglyceride mmol/1 129 1"678
Urea mmol/1 124 7.349
Creatinine [mol/1 125 99"0
AST U/1 122 34"65
ALT U/1 123 36"63
ALP U/1 120 278"5
Sodium mmol/1 84 141" 7
Potassium mmol/1 84 4"34
Chloride mmol/1 115 104"3
Magnesium mmol/1 80 0"85
Iron tmol/1 150 13"80
6"066 0"9782 0"014 0"9965 0"2342
4"377 1"0000 -0"078 0"9876 0"2125
59"05 0"9670 -0"735 0"9988 5"2670
1"485 0"9024 -0"046 0"9952 0"1110
7"680 1"0263 0"138 0"9938 0"3940
106"1 1"0796 -0"619 0"9933 4"9504
33"34 0"8727 3"06 0"9991 1"5482
39"33 1"0156 2"66 0"9987 1"9926
245"1 0"8258 14"59 0"9996 6"1573
140.1 0"9375 7"20 0"9346 1"1942
4"21 0"9732 -0"006 0"9970 0"0443
104"2 1"0000 0"000 0"9730 1"2314
0"885 0"9800 0"045 0"9790 0"0505
13"87 0"9870 0"234 0"9880 1"2351
209F. Ceriotti et al. Evaluation of the Monarch clinical chemistry analyser
each chemistry was preceded and followed by the other.
It was considered that no carry-over had occurred if the
variations in a certain sequence were within twice the CV
of the method obtained in the within-batch precision.
Results and discussions
Imprecision
The different components of the imprecision were calcu-
lated according to the analysis ofvariance [2]; the results
are shown in table 2. The within-run precision was
acceptable in the majority of cases. The overall precision
of the electrolyte determinations was excellent (CVs
always lower than 1% in the case of sodium, and lower
than 1"25 for potassium and chloride) and was good for
every other analyte tested, with the exception of choles-
terol and urea at low concentrations.
Table 9. Sample-dependent carry-over.
%
Analyte High pool Low pool carry-over
Glucose 64.93 mmol/1 1"28 mmol/1 0"03
Cholesterol 6"73 mmol/1 1"66 mmol/1 0"30
Total bilirubin 241 tmol/1 6"5 tmol/1 0"07
Triglyceride 8"25 mmol/1 0"95 mmol/1 0"06
Urea 40"0 mmol/1 3"83 mmol/1 0"05
Creatinine 1200 tmol/l 79"6 mol/1 0"24
AST 269 U/1 18 U/1 0"02
ALT 381 U/1 23 U/1 0"10
ALP 845 U/I 69 U/i 0"01
Sodium 162 mmol/1 110 mmol/1 0"04
Potassium 5’0 mmol/1 3’8 mmol/1 0"60
Chloride 120 mmol/1 84 mmol/1 0"00
Calibration stability
Results are shown in table 3. The stability of the
calibration seemed to be good, and a significant trend
exists only in the case of urea, calcium and magnesium.
For these analytes a daily calibration is advised.
Photometric and dispensing accuracy
As shown in table 4, the accuracy of the photometric
system seemed acceptable. Also when bichromate was
dispensed.as a sample, the results were good (table 5);
however, when it was used as a reagent, both instruments
showed a consistent negative bias (table 6). This is not
very important if the instrument is calibrated with
external calibrators. When using the diluted bichromate
solution (see table 5 second half, and table 6), the
experimental design does not allow the operator to
distinguish between imprecision and inaccuracy due to
the photometric system or to the dispensing device. The
absorbances obtained were therefore compared with the
theoretical value for a similar dilution of the solution. So
it is possible to evaluate the overall accuracy of the
system, but the components ofany imprecision cannot be
identified. The linearity of response was also calculated
using the formulas proposed by Burnett and Martin [3,
4]. In each of the three cases, the curvilinear probability
was not significant (pre-load mode p 0"5110 r
0"9996, bichromate as sample p 0" 11418 r2 0"9996,
bichromate as reagent p 0"3371 r 0"9998.
Linearity
As shown in table 7, the linearity of the IL methods was
very good and almost always higher than that claimed by
the manufacturer.
Carry-ouer
The specimen-dependent carry-over was found to be
negligible for all the methods studied (table 9). A
significant method-to-method carry-over was found only
when total protein determination was followed by urate
measurement. In this case, the urate value was reduced.
This is caused by a falsely elevated reagent blank. Should
such a combination occur during calibration, an import-
ant increase of all the urate values would be observed.
The absorbance increase ofan urate reagent blank after a
total protein assay (0"046 Abs) was similar to that found
by adding one part of biuret reagent to 500 parts of urate
reagent and reading the absorbance after an incubation of
5 min at 37C (0"052 Abs). Therefore, a reagent carry-
over of about 1/500 can be assumed; this is evident only
when particular reagent combinations occur. No carry-
over was found when an ALT was followed by an LDH
assay (a combination that is highly critical in other
random access analysers [5]), nor was there any carry-
over vith any other combination of the analytes tested.
Method comparison
Data and correlation parameters are presented in table 3.
The regression line was computed with the non-
parametric linear regression model of Passing and
Bablock [6]. The correlation coefficient (r) was g6od, or
very good, in every case (only for sodium was it somewhat
lower, but the range tested was very narrow). The slope of
the regression line shows that, in the cases of triglyceride,
AST and ALP, there was an important negative pro-
portional bias. This bias could be explained for triglycer-
ide because ofthe differnt kinds ofmethod and calibration
material used and for AST and ALP by the different
optimization of the methods, and the use (by the Hitachi
737) of a calibrator for enzymatic analyses.
Conclusions
The overall performance of the apparatus seemed to be
satisfactory. The instrument is extremely flexible and
suitable for development and application ofnew reagents
and research methods, and, moreover, showed a good
reliability. It is now used as the routine clinical chemistry
analyser in two of the three laboratories who took part in
the evaluation.
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PROCESS ANALYSIS: A ROAD TO SAFETY AND EFFICIENCY
A residential school to be heldfrom 29 April to 4 May 1990 at University of Warwick, UK
The Institute of Measurement and Control is running the twelfth in a successful series of schools on process
analytical instrumentation. It aims to provide participants with an updated knowledge of current analytical
techniques and an understanding of how automated chemical analysis aids profitability, safety and
environmental control through a number of lectures and syndicate project work.
The schools serve a useful purpose and meet a real demand by a number of industries such as the chemical,
petrochemical, metal manufacturing, power generation, food processing and process industries using analytical
instruments to profitable and safe effect.
The 1990 fees which include attendance, accommodation, meals, and documentation for the duration of the
course will be 650 for members and 700 for non-members plus VAT.
Lecture topics will include: The Case for Process Analysis; System Design Considerations; Sampling; Signal
Processing, Data Handling and Communications; Calibration and Validation; Cost Effective Maintenance of
Analysers; Electroanalytical Principles and Applications; Spectrophotometric Analysis; Chromatography;
Mass Spectrometry; Efficient Combustion and Pollution Control by Gas Analysis; Measurement ofWater and
Effluent Streams; Monitoring Gaseous Effluents; Flammable Gas Detectors; Chemometrics; Safety
Considerations; Miscellaneous Analytical Techniques; and A Review of Future Trends in Process Analytical
Instrumentation.
Further details can be obtainedfrom: The InstMC, 87 Gower Street, London WC1E 6AA, UK. Tel.: (01) 387 4949.
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